Ethyl 8-formyl-1,4-dioxaspiro[4.5]decane-8-carboxylate, 95.0%, 250mg

1,1'-DIMETHYL-2,2'-BIPYRIDINIUM DIIODIDE, 95%, 5g

Hydrochloric acid in 2-propanol, 0.1 mol/l - 0.1 N standard solution, 1 l, glass packaging

(3aR,4R,6aS)-5-benzyl-4-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyrrole, 98%, 50mg

Fmoc-3-hydroxyazetidine, 98.0%, 5g

Diisopropyl 3-oxocyclobutane-1,1-dicarboxylate, 95.0%, 100g

Ethyl 3-hydrazinylpropanoate hydrochloride, 97%, 1g

1-(Pyridin-3-yl)cyclopropanecarboxylic acid, 95.0%, 250mg

3-Chloro-2-formylphenylboronic acid pinacol ester, 95+%, 1g

4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,1,3-benzothiadiazole>95.0%(GC)1g

2-(4-METHYLPHENYL)-1,2-BENZISOTHIAZOL-3(2H)-ONE, 95.0%, 5mg

(E)-1-(4-Methoxyphenyl)-N-(4-((E)-styryl)phenyl)methanimine, 95%, 250mg

5-Nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 250mg